Levine Leichtman Capital Partners Portfolio Company Therapeutic Research Center Acquires CriticalPoint and Clinical IQ

Therapeutic Research Center, LLC (“TRC”), a portfolio company of Levine Leichtman Capital Partners (“LLCP”), announced that it has acquired CriticalPoint, LLC (“CriticalPoint”) and Clinical IQ, LLC (“Clinical IQ”). CriticalPoint is the premier provider of training programs and educational offerings focused on sterile and non-sterile compounding and Clinical IQ is the leading provider of consulting services in the areas of compounding, CGMP aseptic processing and USP <795>, <797> and <800> compliance. TRC is a leading provider of original, independent, and clinically referenced recommendations and education on drug therapy and medication management for pharmacists and other healthcare professionals.

Read the full article: Levine Leichtman Capital Partners Portfolio Company Therapeutic Research Center Acquires CriticalPoint and Clinical IQ //

Source: https://www.prnewswire.com/news-releases/levine-leichtman-capital-partners-portfolio-company-therapeutic-research-center-acquires-criticalpoint-and-clinical-iq-301037224.html

Scroll to Top